Pfizer's weight loss pivot: a £7.3 billion ai opportunity for savvy investors
Pfizer is back in the weight loss drug race, acquiring Medcurrent for up to £7.3 billion. This isn't just big pharma news; it's a monumental AI oppor...
Pfizer is back in the weight loss drug race, acquiring Medcurrent for up to £7.3 billion. This isn't just big pharma news; it's a monumental AI oppor...
Shell just announced its 15th straight quarter of huge share buybacks, even as oil prices dip! This isn't just news; it's a masterclass in capital all...
Ever caught yourself eyeing those 'instant 10X' investments in meme stocks or low-quality plays? Josh Brown, with a healthy dose of Larry David-esque ...